Product Catalog []

Colorectal Cancer access options

Globally, colorectal cancer is the third most common type of cancer making up about 10% of all cancer cases. In 2012 there were 1.4 million new cases and 694,000 deaths from colorectal cancer. The 5-year survival rates in the United States are around 65%. Colorectal cancer typically starts with a benign tumour. Colorectal cancer typically starts with a benign tumour, often in the form of a polyp, which over time becomes cancerous. Treatment options are depending on the stage of the disease, overall health and preferences of the patient. Standard treatments include surgery, chemotherapy, radiotherapy or a combination.
  1. Opdivo
    Opdivo (Nivolumab)
    Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €867.24
  2. Lonsurf
    Lonsurf (trifluridine/tipiracil)
    Colorectal Cancer
    €810.00
  3. Keytruda
    Keytruda (pembrolizumab)
    Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €4,225.50
  4. Cyramza
    Cyramza (ramucirumab)
    Colorectal Cancer, Gastric Cancer, Lung Cancer
    €640.06
  5. Xeloda
    Xeloda
    Price available on request
  6. Braftovi
    Braftovi (encorafenib)
    Colorectal Cancer, Skin Cancer
    €901.88
  7. Vegzelma
    Vegzelma (bevacizumab-adcd)
    Colorectal Cancer, Gynaecological Cancer, Kidney Cancer, Liver Cancer, Lung Cancer
    €769.57
  8. Fruzaqla
    Fruzaqla (fruquintinib)
    Colorectal Cancer
    €9,727.94
View as Grid List

8 Items

Set Descending Direction
Read more about the latest treatments in Colorectal Cancer
US 0